Therapy Areas: Inflammatory Diseases
NovaBay Pharmaceuticals Launches Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
12 January 2022 - - US-based pharmaceutical company NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has expanded its Avenova brand with the launch of its Lubricant Eye Drops, the company said.

These lubricating eye drops feature innovative ingredients and a mode of action that's new to the eyecare market and formulated to bring immediate relief to those who suffer from the symptoms of dry eye.

The Lubricating Eye Drops are an especially good value when compared to competitors, with two 15ml bottles sold as a twin pack for USD 19.99.

The drops can be ordered directly online.

They are also available to eye care specialists for resale to their patients through NovaBay's physician dispensed channel. Product photos available upon request.

Dry eye is a medical condition that occurs when there are insufficient tears to lubricate and nourish the eye, according to the American Optometric Association.

Tears are necessary for maintaining the health of the front surface of the eye and for providing clear vision.

People with dry eyes may experience irritated, gritty, scratchy or burning eyes, as well as excess watering, blurred vision and the feeling that something is in their eyes.

Among the causes of dry eye are inadequate tear production, poor tear quality, age, medication, medical conditions such as blepharitis, environmental conditions including exposure to smoke, wind and dry climate, and other factors such as refractive eye surgery and contact lenses.

Avenova Lubricating Eye Drops are part of NovaBay's "science for sore eyes" three-step daily regimen to help relieve symptoms for dry eye sufferers, all from the comfort of their homes.

First, using the Lubricating Eye Drops leaves eyes feeling immediately soothed. Second, applying the Avenova Warm Eye Compress unclogs glands so that the body can produce its own tears.

And third, using the Avenova Lid and Lash Solution patented spray helps relieve chronic eye conditions like bacterial dry eye, blepharitis, Meibomian gland dysfunction, contact lens intolerance and inflammation.

Avenova antimicrobial Lid and Lash Solution is the No. 1 eyelid and lash cleanser in the US dry eye market and is the only product clinically proven to treat the underlying cause of bacterial dry eye.

The Lubricating Eye Drops do not contain hypochlorous acid and do not have an antimicrobial effect.

They do however provide immediate symptomatic relief. For the best clinical outcome, it is important that customers use all three products together. Each product has its own mechanism of action and helps dry eye sufferers in their own unique way.

NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets.

Avenova is the most prescribed antimicrobial lid and lash spray and CelleRx is a breakthrough product in the beauty category.

In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.


Related Headlines